PMC:7796041 / 37607-38804 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1104","span":{"begin":1030,"end":1034},"obj":"Chemical"},{"id":"1105","span":{"begin":1142,"end":1146},"obj":"Chemical"},{"id":"1106","span":{"begin":0,"end":10},"obj":"Disease"},{"id":"1107","span":{"begin":24,"end":34},"obj":"Disease"},{"id":"1108","span":{"begin":151,"end":163},"obj":"Disease"},{"id":"1109","span":{"begin":193,"end":215},"obj":"Disease"},{"id":"1110","span":{"begin":246,"end":260},"obj":"Disease"},{"id":"1111","span":{"begin":358,"end":366},"obj":"Disease"},{"id":"1112","span":{"begin":557,"end":574},"obj":"Disease"},{"id":"1113","span":{"begin":603,"end":619},"obj":"Disease"}],"attributes":[{"id":"A1104","pred":"tao:has_database_id","subj":"1104","obj":"MESH:D006495"},{"id":"A1105","pred":"tao:has_database_id","subj":"1105","obj":"MESH:D006495"},{"id":"A1106","pred":"tao:has_database_id","subj":"1106","obj":"MESH:D001145"},{"id":"A1107","pred":"tao:has_database_id","subj":"1107","obj":"MESH:D001145"},{"id":"A1108","pred":"tao:has_database_id","subj":"1108","obj":"MESH:D006973"},{"id":"A1109","pred":"tao:has_database_id","subj":"1109","obj":"MESH:D002318"},{"id":"A1110","pred":"tao:has_database_id","subj":"1110","obj":"MESH:D009202"},{"id":"A1111","pred":"tao:has_database_id","subj":"1111","obj":"MESH:D003920"},{"id":"A1112","pred":"tao:has_database_id","subj":"1112","obj":"MESH:D008171"},{"id":"A1113","pred":"tao:has_database_id","subj":"1113","obj":"MESH:D007153"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Arrhythmia (n = 34) No Arrhythmia (n = 132) p Value *\nFemale 11 (32.4) 47 (35.6) 0.817\nAge (years), mean ± SD 73.6 ± 12.8 61.6 ± 16.7 \u003c0.001 †\nHypertension 26 (76.5) 57 (43.2) 0.001\nCardiovascular disease 14 (41.2) 16 (12.1) \u003c0.001\nCardiomyopathy 1 (2.9) 4 (3.0) 1.000\nLVEF (%), mean ± SD 57.1 ± 8.2 (n = 16) 45.7 ± 14.9 (n = 28) 0.002 †\nDiabetes 7 (20.6) 22 (16.7) 0.566\nObesity 7 (23.3) (n = 30) 29 (26.9) (n = 108) 0.789\nBody mass index (kg/m2) median (P25; P75) 24.1 (20.9; 25.1) (n = 17) 23.3 (20.6; 25.7) (n = 80) 0.939 ‡\nPulmonary disease 6 (17.6) 18 (13.6) 0.566\nImmunodeficiency 4 (7.6) 10 (11.8) 0.441\nQRS duration (ms), median (P25; P75) 95.5 (90.0; 107) (n = 24) 95.0 (90.0; 105) (n = 107) 0.797 ‡\nQTc duration (ms), median (P25; P75) 430 (400; 470) (n = 24) 407 (393; 425) (n = 107) 0.012 ‡\nHydroxychloroquine 15 (44.1) 59 (44.6) 1.000\nHydroxychloroquine + azithromycin 7 (20.6) 20 (15.2) 0.424\nAnticoagulation therapy 24 (80.0) (n = 30) 27 (23.3) (n = 116) \u003c0.001\n- LMWH/UFH 15 (50.0) 17 (14.7) \u003c0.001\n- Oral anticoagulants 9 (30.0) 10 (8.6) 0.005\nThromboprophylaxis with LMWH/UFH 5 (16.7) (n = 30) 52 (44.8) (n = 116) 0.004"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T233","span":{"begin":0,"end":10},"obj":"Phenotype"},{"id":"T234","span":{"begin":24,"end":34},"obj":"Phenotype"},{"id":"T235","span":{"begin":151,"end":163},"obj":"Phenotype"},{"id":"T236","span":{"begin":193,"end":215},"obj":"Phenotype"},{"id":"T237","span":{"begin":246,"end":260},"obj":"Phenotype"},{"id":"T238","span":{"begin":395,"end":402},"obj":"Phenotype"},{"id":"T239","span":{"begin":603,"end":619},"obj":"Phenotype"}],"attributes":[{"id":"A233","pred":"hp_id","subj":"T233","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A234","pred":"hp_id","subj":"T234","obj":"http://purl.obolibrary.org/obo/HP_0011675"},{"id":"A235","pred":"hp_id","subj":"T235","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A236","pred":"hp_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A237","pred":"hp_id","subj":"T237","obj":"http://purl.obolibrary.org/obo/HP_0001638"},{"id":"A238","pred":"hp_id","subj":"T238","obj":"http://purl.obolibrary.org/obo/HP_0001513"},{"id":"A239","pred":"hp_id","subj":"T239","obj":"http://purl.obolibrary.org/obo/HP_0002721"}],"text":"Arrhythmia (n = 34) No Arrhythmia (n = 132) p Value *\nFemale 11 (32.4) 47 (35.6) 0.817\nAge (years), mean ± SD 73.6 ± 12.8 61.6 ± 16.7 \u003c0.001 †\nHypertension 26 (76.5) 57 (43.2) 0.001\nCardiovascular disease 14 (41.2) 16 (12.1) \u003c0.001\nCardiomyopathy 1 (2.9) 4 (3.0) 1.000\nLVEF (%), mean ± SD 57.1 ± 8.2 (n = 16) 45.7 ± 14.9 (n = 28) 0.002 †\nDiabetes 7 (20.6) 22 (16.7) 0.566\nObesity 7 (23.3) (n = 30) 29 (26.9) (n = 108) 0.789\nBody mass index (kg/m2) median (P25; P75) 24.1 (20.9; 25.1) (n = 17) 23.3 (20.6; 25.7) (n = 80) 0.939 ‡\nPulmonary disease 6 (17.6) 18 (13.6) 0.566\nImmunodeficiency 4 (7.6) 10 (11.8) 0.441\nQRS duration (ms), median (P25; P75) 95.5 (90.0; 107) (n = 24) 95.0 (90.0; 105) (n = 107) 0.797 ‡\nQTc duration (ms), median (P25; P75) 430 (400; 470) (n = 24) 407 (393; 425) (n = 107) 0.012 ‡\nHydroxychloroquine 15 (44.1) 59 (44.6) 1.000\nHydroxychloroquine + azithromycin 7 (20.6) 20 (15.2) 0.424\nAnticoagulation therapy 24 (80.0) (n = 30) 27 (23.3) (n = 116) \u003c0.001\n- LMWH/UFH 15 (50.0) 17 (14.7) \u003c0.001\n- Oral anticoagulants 9 (30.0) 10 (8.6) 0.005\nThromboprophylaxis with LMWH/UFH 5 (16.7) (n = 30) 52 (44.8) (n = 116) 0.004"}

{"project":"LitCovid-sentences","denotations":[{"id":"T300","span":{"begin":0,"end":55},"obj":"Sentence"},{"id":"T301","span":{"begin":56,"end":91},"obj":"Sentence"},{"id":"T302","span":{"begin":92,"end":150},"obj":"Sentence"},{"id":"T303","span":{"begin":151,"end":192},"obj":"Sentence"},{"id":"T304","span":{"begin":193,"end":245},"obj":"Sentence"},{"id":"T305","span":{"begin":246,"end":285},"obj":"Sentence"},{"id":"T306","span":{"begin":286,"end":357},"obj":"Sentence"},{"id":"T307","span":{"begin":358,"end":394},"obj":"Sentence"},{"id":"T308","span":{"begin":395,"end":449},"obj":"Sentence"},{"id":"T309","span":{"begin":450,"end":556},"obj":"Sentence"},{"id":"T310","span":{"begin":557,"end":602},"obj":"Sentence"},{"id":"T311","span":{"begin":603,"end":646},"obj":"Sentence"},{"id":"T312","span":{"begin":647,"end":747},"obj":"Sentence"},{"id":"T313","span":{"begin":748,"end":844},"obj":"Sentence"},{"id":"T314","span":{"begin":845,"end":892},"obj":"Sentence"},{"id":"T315","span":{"begin":893,"end":954},"obj":"Sentence"},{"id":"T316","span":{"begin":955,"end":1027},"obj":"Sentence"},{"id":"T317","span":{"begin":1028,"end":1068},"obj":"Sentence"},{"id":"T318","span":{"begin":1069,"end":1117},"obj":"Sentence"},{"id":"T319","span":{"begin":1118,"end":1197},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Arrhythmia (n = 34) No Arrhythmia (n = 132) p Value *\nFemale 11 (32.4) 47 (35.6) 0.817\nAge (years), mean ± SD 73.6 ± 12.8 61.6 ± 16.7 \u003c0.001 †\nHypertension 26 (76.5) 57 (43.2) 0.001\nCardiovascular disease 14 (41.2) 16 (12.1) \u003c0.001\nCardiomyopathy 1 (2.9) 4 (3.0) 1.000\nLVEF (%), mean ± SD 57.1 ± 8.2 (n = 16) 45.7 ± 14.9 (n = 28) 0.002 †\nDiabetes 7 (20.6) 22 (16.7) 0.566\nObesity 7 (23.3) (n = 30) 29 (26.9) (n = 108) 0.789\nBody mass index (kg/m2) median (P25; P75) 24.1 (20.9; 25.1) (n = 17) 23.3 (20.6; 25.7) (n = 80) 0.939 ‡\nPulmonary disease 6 (17.6) 18 (13.6) 0.566\nImmunodeficiency 4 (7.6) 10 (11.8) 0.441\nQRS duration (ms), median (P25; P75) 95.5 (90.0; 107) (n = 24) 95.0 (90.0; 105) (n = 107) 0.797 ‡\nQTc duration (ms), median (P25; P75) 430 (400; 470) (n = 24) 407 (393; 425) (n = 107) 0.012 ‡\nHydroxychloroquine 15 (44.1) 59 (44.6) 1.000\nHydroxychloroquine + azithromycin 7 (20.6) 20 (15.2) 0.424\nAnticoagulation therapy 24 (80.0) (n = 30) 27 (23.3) (n = 116) \u003c0.001\n- LMWH/UFH 15 (50.0) 17 (14.7) \u003c0.001\n- Oral anticoagulants 9 (30.0) 10 (8.6) 0.005\nThromboprophylaxis with LMWH/UFH 5 (16.7) (n = 30) 52 (44.8) (n = 116) 0.004"}